The Global Oroxylin A Market was valued at USD 28.7 Million in 2024 and is projected to reach USD 42.9 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period (2024–2030). This growth is propelled by increasing clinical validation of Oroxylin A’s therapeutic benefits in oncology, neurology, and cardiovascular applications, along with growing demand for plant-derived pharmaceuticals.

As research institutions and pharmaceutical companies intensify focus on flavonoid-based therapies, Oroxylin A (5,7-Dihydroxy-6-methoxyflavone) has emerged as a compound of significant interest. This report profiles the Top 10 Companies in the Oroxylin A Market – specialized manufacturers, suppliers, and research partners driving innovation in production and application development.

---

🔟 1. BOC Sciences

Headquarters: Shirley, New York, USA
Specialization: High-purity (98-99%) Oroxylin A for pharmaceutical R&D

A globally recognized biochemical supplier, BOC Sciences provides research-grade and GMP-quality Oroxylin A to academic institutions and pharmaceutical developers worldwide, with comprehensive analytical documentation for regulatory compliance.

Technical Capabilities:

• Custom purity specifications from 95% to 99.5%
• Stable isotope-labeled standards for pharmacokinetic studies
• FDA Drug Master File (DMF) support available

Download FREE Sample Report: Global Oroxylin A Market – View in Detailed Research Report

---

9️⃣ 2. Yunnan Xili Biotechnology

Headquarters: Kunming, Yunnan, China
Specialization: Botanical extraction of Oroxylin A from Scutellaria species

As a leader in plant-derived bioactive compounds, Yunnan Xili combines traditional Chinese medicine expertise with modern extraction technologies to produce standardized Oroxylin A extracts for therapeutic formulations.

Technical Capabilities:

• Vertically integrated from cultivation to final product
• ESG-compliant sourcing from GACP-certified farms

---

8️⃣ 3. Chengdu Gleep Biotechnology

Headquarters: Chengdu, Sichuan, China
Specialization: Pharmaceutical-grade Oroxylin A manufacturing

Chengdu Gleep operates one of China’s largest flavonoid production facilities, employing patented purification technologies to achieve industry-leading yields of >98% pure Oroxylin A.

Technical Capabilities:

• 1.5-ton annual production capacity
• ISO 13485 certified clean rooms

---

7️⃣ 4. Shanghai Jiji Biochemical Technology

Headquarters: Shanghai, China
Specialization: Analytical standards and bulk Oroxylin A supply

Shanghai Jiji serves as a critical supplier to pharmacokinetic research projects, providing reference materials with complete characterization data for regulatory submissions.

Technical Capabilities:

• Full NMR, HPLC-MS, and elemental analysis documentation
• Stability studies under ICH guidelines

Download FREE Sample Report: Global Oroxylin A Market – View in Detailed Research Report

---

6️⃣ 5. Shanghai Yuanye Biotechnology

Headquarters: Shanghai, China
Specialization: Preclinical and clinical trial materials

With stringent quality controls exceeding pharmacopeial standards, Shanghai Yuanye supplies GLP/GMP-grade Oroxylin A to global drug development programs.

Technical Capabilities:

• Biological activity testing services
• Impurity profiling per ICH Q3 guidelines

---

5️⃣ 6. Hubei Wanzhi Chemical Pharmaceutical

Headquarters: Wuhan, Hubei, China
Specialization: Synthetic and natural-source Oroxylin A

This dual-capability manufacturer offers both plant-derived and chemically synthesized Oroxylin A, providing formulation developers with sourcing flexibility.

Technical Capabilities:

• 300kg/month integrated production
• Solubility enhancement technologies

---

4️⃣ 7. Sichuan Province Vikki Biotechnology

Headquarters: Chengdu, Sichuan, China
Specialization: Standardized extract formulations

Vikki Biotechnology specializes in multi-component Oroxylin A formulations that preserve synergistic phytochemical relationships from source plants.

Technical Capabilities:

• Clinically validated extract ratios
• Bioavailability enhancement platforms

---

3️⃣ 8. Jiangsu Yongjian Medical Technology

Headquarters: Nanjing, Jiangsu, China
Specialization: Drug delivery system integration

Jiangsu Yongjian develops advanced Oroxylin A formulations including liposomal, nanoparticle, and sustained-release systems for improved therapeutic outcomes.

Technical Capabilities:

• 14 formulation patents
• Preclinical efficacy testing services

---

2️⃣ 9. Nutra Green Biotechnology

Headquarters: Xi’an, Shaanxi, China
Specialization: Organic-certified Oroxylin A production

As demand grows for certified organic ingredients, Nutra Green provides USDA/EU organic-compliant Oroxylin A extracts for premium nutraceutical applications.

Technical Capabilities:

• Full organic certification chain
• Residue-free production processes

---

1️⃣ 10. Xi’an Natural Field Bio-Technique

Headquarters: Xi’an, Shaanxi, China
Specialization: Clinical-grade standardization

This research-focused company provides batch-consistent Oroxylin A materials with comprehensive pharmacological data packages for IND submissions.

Technical Capabilities:

• Phase I-III clinical trial support
• Pharmacokinetic profiling services

Get Full Report Here: Global Oroxylin A Market – View in Detailed Research Report

---

🧪 Market Outlook: Therapeutic Potential Driving Growth

The Oroxylin A market is transitioning from research curiosity to clinical reality, with multiple drug candidates now in human trials. Market expansion will be fueled by these key developments:

📈 Major Industry Trends:

• 42% of oncology research programs now evaluating Oroxylin A combinations
• FDA fast track designation for two Oroxylin A-derived neuroprotective agents
• New extraction methods reducing production costs by 18-22% annually
• Regulatory harmonization for botanical drug approvals across major markets

Get Full Report Here: Global Oroxylin A Market – View in Detailed Research Report

The profiled companies represent the vanguard of Oroxylin A commercialization, bridging traditional phytochemistry with modern pharmaceutical science to unlock this compound’s full therapeutic potential.